Wolverine Asset Management LLC bought a new position in Drugs Made In America Acquisition II Corp. (NASDAQ:DMII – Free Report) in the 4th quarter, HoldingsChannel reports. The fund bought 1,062,773 shares of the company’s stock, valued at approximately $10,521,000.
Separately, Deltec Asset Management LLC bought a new position in Drugs Made In America Acquisition II in the 4th quarter worth about $495,000.
Analyst Ratings Changes
A number of research firms recently commented on DMII. Wall Street Zen upgraded shares of Drugs Made In America Acquisition II to a “sell” rating in a research note on Saturday. Weiss Ratings began coverage on shares of Drugs Made In America Acquisition II in a research note on Monday, March 2nd. They set a “sell (e)” rating on the stock. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has an average rating of “Sell”.
Drugs Made In America Acquisition II Stock Performance
NASDAQ DMII opened at $10.02 on Monday. Drugs Made In America Acquisition II Corp. has a 1 year low of $9.86 and a 1 year high of $10.02. The firm has a fifty day moving average of $9.98.
Drugs Made In America Acquisition II Company Profile
Drugs Made In America Acquisition II (NASDAQ:DMII) is a special purpose acquisition company (SPAC) formed to raise capital through a public listing for the purpose of effecting a business combination. As a blank?check vehicle, the company itself does not operate a traditional commercial business; instead, it seeks to identify, negotiate and complete an acquisition, merger, share exchange, asset purchase or similar business transaction with one or more target companies.
The stated investment focus reflected in the company’s name indicates an emphasis on the pharmaceutical and life sciences sector, with a particular interest in domestic drug manufacturing, supply?chain resiliency and related healthcare operations in the United States.
See Also
Want to see what other hedge funds are holding DMII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Drugs Made In America Acquisition II Corp. (NASDAQ:DMII – Free Report).
Receive News & Ratings for Drugs Made In America Acquisition II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drugs Made In America Acquisition II and related companies with MarketBeat.com's FREE daily email newsletter.
